vimarsana.com

Latest Breaking News On - Aigen investment management - Page 1 : vimarsana.com

Forest Hill Capital LLC Sells 32,313 Shares of Banner Co (NASDAQ:BANR)

Forest Hill Capital LLC decreased its holdings in shares of Banner Co. (NASDAQ:BANR – Free Report) by 14.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 185,118 shares of the financial services provider’s stock after selling 32,313 shares during the quarter. Banner […]

Veracyte, Inc (NASDAQ:VCYT) Director Karin Eastham Sells 2,500 Shares

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) Director Karin Eastham sold 2,500 shares of the stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $20.97, for a total transaction of $52,425.00. Following the completion of the transaction, the director now directly owns 33,125 shares of […]

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Shares Sold by Avidity Partners Management LP

Avidity Partners Management LP lessened its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 96.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,501 shares of the company’s stock after selling 1,692,439 shares during the quarter. Avidity Partners Management […]

5,644,898 Shares in MaxCyte, Inc (NASDAQ:MXCT) Acquired by Cadian Capital Management LP

Cadian Capital Management LP acquired a new position in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,644,898 shares of the company’s stock, valued at approximately $26,531,000. MaxCyte comprises about 1.1% of Cadian […]

Avoro Capital Advisors LLC Has $261 01 Million Stake in Xenon Pharmaceuticals Inc (NASDAQ:XENE)

Avoro Capital Advisors LLC grew its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 15.6% during the 4th quarter, HoldingsChannel reports. The firm owned 5,666,666 shares of the biopharmaceutical company’s stock after acquiring an additional 766,666 shares during the quarter. Xenon Pharmaceuticals comprises about 3.6% of Avoro Capital Advisors LLC’s investment portfolio, making […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.